Published in Kidney Int on January 01, 2002
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Rosuvastatin in diabetic hemodialysis patients. J Am Soc Nephrol (2011) 1.85
Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J (2014) 1.57
Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol (2010) 1.20
Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality. BMC Nephrol (2003) 1.17
Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol (2009) 1.09
Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J (2011) 1.06
Cardioprotective medication use in hemodialysis patients. Can J Cardiol (2006) 0.98
Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol (2007) 0.98
Effects of statin treatment in patients with coronary artery disease and chronic kidney disease. Heart Vessels (2013) 0.97
Managing dyslipidemia in chronic kidney disease. J Gen Intern Med (2004) 0.96
Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease. Arch Med Sci (2013) 0.92
An update on coronary artery disease and chronic kidney disease. Int J Nephrol (2014) 0.89
Ongoing clinical trials of the pleiotropic effects of statins. Vasc Health Risk Manag (2005) 0.89
Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study. Curr Control Trials Cardiovasc Med (2005) 0.87
Clinical assessment and management of dyslipidemia in patients with chronic kidney disease. Clin Exp Nephrol (2012) 0.86
Mechanisms for increased cardiovascular disease in chronic kidney dysfunction. Curr Opin Nephrol Hypertens (2009) 0.86
Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease. Nephrol Dial Transplant (2012) 0.85
Treatment of dyslipidemia in chronic kidney disease: Effectiveness and safety of statins. World J Nephrol (2012) 0.85
Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney Blood Press Res (2007) 0.84
A multidisciplinary program for achieving lipid goals in chronic hemodialysis patients. BMC Nephrol (2002) 0.80
Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients. Clin Exp Nephrol (2012) 0.79
Does Pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients? Nutr J (2014) 0.79
Geographic variation in HMG-CoA reductase inhibitor use in dialysis patients. J Gen Intern Med (2012) 0.77
Coronary risk assessment and management options in chronic kidney disease patients prior to kidney transplantation. Curr Cardiol Rev (2009) 0.77
Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials. PLoS Med (2006) 0.76
The lipid story in chronic kidney disease: a long story with a happy end? Int Urol Nephrol (2013) 0.76
Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin. Clin J Am Soc Nephrol (2013) 0.75
Survival Benefit of Statins in Hemodialysis Patients Awaiting Renal Transplantation. Int J Angiol (2015) 0.75
Dyslipidemia in children with CKD: should we treat with statins? Pediatr Nephrol (2011) 0.75
Balancing the Evidence: How to Reconcile the Results of Observational Studies vs. Randomized Clinical Trials in Dialysis. Semin Dial (2016) 0.75
Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction. Diabetol Metab Syndr (2017) 0.75
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol (2004) 6.59
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82
Trends in bariatric surgical procedures. JAMA (2005) 5.67
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA (2004) 4.71
Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA (2011) 4.70
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology (2013) 4.43
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Outcomes of planned home births in Washington State: 1989-1996. Obstet Gynecol (2002) 3.99
Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology (2002) 3.28
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet (2008) 3.23
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol (2009) 3.12
Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA (2012) 3.10
Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst (2005) 3.06
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA (2003) 3.04
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection. Hepatology (2013) 2.98
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol (2009) 2.87
Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med (2009) 2.83
Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology (2004) 2.82
Moderate renal impairment and risk of dementia among older adults: the Cardiovascular Health Cognition Study. J Am Soc Nephrol (2004) 2.82
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76
Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. JAMA (2008) 2.76
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis (2004) 2.62
Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspect (2008) 2.59
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol (2008) 2.47
Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.46
25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2007) 2.40
Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int (2004) 2.37
Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med (2008) 2.33
Recent trials in hypertension: compelling science or commercial speech? JAMA (2006) 2.30
Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol (2013) 2.28
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med (2011) 2.27
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Association between physical performance and all-cause mortality in CKD. J Am Soc Nephrol (2013) 2.26
Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg (2009) 2.21
Male circumcision in Siaya and Bondo Districts, Kenya: prospective cohort study to assess behavioral disinhibition following circumcision. J Acquir Immune Defic Syndr (2007) 2.21
Incidence of suicide in persons with cancer. J Clin Oncol (2008) 2.21
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Effect of acute lung injury and acute respiratory distress syndrome on outcome in critically ill trauma patients. Crit Care Med (2004) 2.20
Dietary phosphorus is associated with greater left ventricular mass. Kidney Int (2013) 2.19
Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol (2007) 2.15
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10
Tradeoffs between accuracy measures for electronic health care data algorithms. J Clin Epidemiol (2011) 2.06
Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms. Environ Health Perspect (2009) 2.06
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med (2008) 2.01
Reporting participation in case-control studies. Epidemiology (2002) 1.99
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int (2005) 1.96
Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med (2002) 1.96
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis (2010) 1.93
Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92
A prospective study of frailty in nephrology-referred patients with CKD. Am J Kidney Dis (2012) 1.90
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer Screening. Med Care (2013) 1.88
Cystatin C and subclinical brain infarction. J Am Soc Nephrol (2005) 1.88
Risk of hip fracture among dialysis and renal transplant recipients. JAMA (2002) 1.81
The prevalence of knee pain and symptomatic knee osteoarthritis among veteran traumatic amputees and nonamputees. Arch Phys Med Rehabil (2005) 1.81
The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis (2011) 1.79
Environment or host?: A case-control study of risk factors for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2012) 1.78
Incidence of primary urethral carcinoma in the United States. Urology (2006) 1.78
Trends in treatment of advanced epithelial ovarian cancer in the Medicare population. Gynecol Oncol (2011) 1.77
Association between serum uric acid level and chronic liver disease in the United States. Hepatology (2010) 1.76
Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care (2009) 1.74
The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology (2004) 1.74
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl. Kidney Int (2005) 1.74
A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int (2008) 1.72
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol (2009) 1.72
Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial. Pediatr Crit Care Med (2013) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis (2002) 1.69
Associations of primary and secondary organic aerosols with airway and systemic inflammation in an elderly panel cohort. Epidemiology (2010) 1.68
Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev (2005) 1.68
Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy. Am J Epidemiol (2012) 1.68
Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med (2010) 1.66
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology (2006) 1.65